Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review
- PMID: 23975473
- PMCID: PMC6509353
- DOI: 10.1007/s10461-013-0593-y
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review
Abstract
Needle-syringe programs (NSP) have been effective in reducing HIV and hepatitis C (HCV) infection among people who inject drugs (PWID). Achieving sustainable reductions in these blood-borne infections requires addressing structural factors so PWID can legally access NSP services. Systematic literature searches collected information on NSP coverage and changes in HIV or HCV infection prevalence or incidence at the population level. Included studies had to document biomarkers (HIV or HCV) coupled with structural-level NSP, defined by a minimum 50 % coverage of PWID and distribution of 10 or more needles/syringe per PWID per year. Fifteen studies reported structural-level NSP and changes in HIV or HCV infection prevalence/incidence. Nine reported decreases in HIV prevalence, six in HCV infection prevalence, and three reported decreases in HIV incidence. The results support NSP as a structural-level intervention to reduce population-level infection and implementation of NSP for prevention and treatment of HIV and HCV infection.
Conflict of interest statement
Figures
Similar articles
-
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.BMC Public Health. 2013 Jan 19;13:53. doi: 10.1186/1471-2458-13-53. BMC Public Health. 2013. PMID: 23332005 Free PMC article.
-
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article.
-
Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.BMC Public Health. 2017 Apr 11;17(1):309. doi: 10.1186/s12889-017-4210-2. BMC Public Health. 2017. PMID: 28399843 Free PMC article.
-
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.Lancet Glob Health. 2017 Dec;5(12):e1208-e1220. doi: 10.1016/S2214-109X(17)30373-X. Epub 2017 Oct 23. Lancet Glob Health. 2017. PMID: 29074410 Free PMC article.
-
Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.Addiction. 2017 Feb;112(2):236-247. doi: 10.1111/add.13593. Epub 2016 Oct 19. Addiction. 2017. PMID: 27566970
Cited by
-
High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012.Am J Public Health. 2015 Jun;105(6):1136-41. doi: 10.2105/AJPH.2014.302473. Epub 2015 Apr 16. Am J Public Health. 2015. PMID: 25880964 Free PMC article. Clinical Trial.
-
Community Support for Harm Reduction and Treatment of Opioid Use Disorder.J Community Health. 2024 Aug;49(4):724-731. doi: 10.1007/s10900-023-01278-6. Epub 2024 Feb 26. J Community Health. 2024. PMID: 38409628
-
Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping.Addict Sci Clin Pract. 2024 Feb 4;19(1):9. doi: 10.1186/s13722-024-00439-9. Addict Sci Clin Pract. 2024. PMID: 38310293 Free PMC article.
-
Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States.Curr Hepatol Rep. 2018 Jun;17(2):111-120. doi: 10.1007/s11901-018-0394-x. Epub 2018 Mar 24. Curr Hepatol Rep. 2018. PMID: 30294518 Free PMC article.
-
Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment.AIDS Behav. 2022 Feb;26(2):385-396. doi: 10.1007/s10461-021-03392-9. Epub 2021 Jul 30. AIDS Behav. 2022. PMID: 34331177 Free PMC article.
References
-
- Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis. 1994;170(6): 1410–7. - PubMed
-
- Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M,Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP, 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45. - PubMed
-
- Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105(5):844–59. - PubMed
-
- Anderson E, Gans J, Shwayder P, Scofield J, Catizone C. HIV prevention and access to sterile syringes. National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention; Atlanta; 1999.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical